J N Kyula
Overview
Explore the profile of J N Kyula including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
4
Citations
112
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Mansfield D, Kyula J, Rosenfelder N, Chao-Chu J, Kramer-Marek G, Khan A, et al.
Gene Ther
. 2016 Jan;
23(4):357-68.
PMID: 26814609
Oncolytic strains of vaccinia virus are currently in clinical development with clear evidence of safety and promising signs of efficacy. Addition of therapeutic genes to the viral genome may increase...
2.
Kyula J, Khan A, Mansfield D, Karapanagiotou E, Mclaughlin M, Roulstone V, et al.
Oncogene
. 2013 Apr;
33(13):1700-12.
PMID: 23624923
Melanoma is an aggressive skin cancer that carries an extremely poor prognosis when local invasion, nodal spread or systemic metastasis has occurred. Recent advances in melanoma biology have revealed that...
3.
Mansfield D, Pencavel T, Kyula J, Zaidi S, Roulstone V, Thway K, et al.
Oral Oncol
. 2012 Aug;
49(2):108-18.
PMID: 22925693
Objective: Oncolytic forms of attenuated Vaccinia virus are now in clinical development, assessing the compatibility of this novel treatment with radiotherapy may reveal exploitable synergistic relationships. Materials And Methods: In...
4.
Roulstone V, Twigger K, Zaidi S, Pencavel T, Kyula J, White C, et al.
Gene Ther
. 2012 Aug;
20(5):521-8.
PMID: 22895509
Oncolytic reovirus is currently under active investigation in a range of tumour types. Early phase studies have shown that this agent has modest monotherapy efficacy and its future development is...